Immune response to green fluorescent protein: implications for gene therapy
- 1 July 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (7), 1305-1312
- https://doi.org/10.1038/sj.gt.3300951
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 38 references indexed in Scilit:
- Green Fluorescent Protein as a Selectable Marker of Fibronectin-Facilitated Retroviral Gene Transfer in Primary Human T LymphocytesHuman Gene Therapy, 1999
- Rapid retroviral infection of human haemopoietic cells of different lineages: efficient transfer in fresh T cellsBritish Journal of Haematology, 1998
- Immune Response to Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Induced by Expression of CD80, Interleukin 2, and Granulocyte-Macrophage Colony-Stimulating FactorHuman Gene Therapy, 1998
- Internal Ribosomal Entry Site-Containing Retroviral Vectors with Green Fluorescent Protein and Drug Resistance MarkersHuman Gene Therapy, 1998
- Enhanced Green Fluorescent Protein as an Efficient Reporter Gene for Retroviral Transduction of Human Multipotent Lymphoid PrecursorsHuman Gene Therapy, 1998
- A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cellsGene Therapy, 1997
- HSV-TK Gene Transfer into Donor Lymphocytes for Control of Allogeneic Graft-Versus-LeukemiaScience, 1997
- Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cellsNature Biotechnology, 1996
- FACS-optimized mutants of the green fluorescent protein (GFP)Gene, 1996
- Green Fluorescent Protein as a Marker for Gene ExpressionScience, 1994